FTH is Faeth Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $39.00. Market cap: $1.01B.
Stock snapshot
| Price | $39.00 |
| Market cap | $1.01B |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
About FTH
Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.
Related non-dividend companies
Other non-dividend stocks investors research alongside FTH. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is FTH's current stock price?
FTH (Faeth Therapeutics, Inc.) is currently trading at $39.00.
Does FTH pay a dividend?
FTH (Faeth Therapeutics, Inc.) does not currently pay a regular dividend.
Track FTH in DiviDrip
Add FTH to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search FTH and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.